A recent meta-analysis has suggested that high levels of IL-8 expression are significantly associated with poor prognosis in CRC patients (HR = 1.54, 95% CI 1.03–2.32) and correlate with advanced stage, lymphatic and liver metastasis, and resistance to antiangiogenic agents8,9. This evidence concerns the gene CXCL8 and colorectal carcinoma.